Published in Clin Chem on January 01, 2003
Antenatal Diagnosis of Placental Attachment Disorders (ADoPAD) | NCT02442518
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43
Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. J Gen Intern Med (2007) 5.24
REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer (2005) 4.85
The SQUIRE (Standards for QUality Improvement Reporting Excellence) guidelines for quality improvement reporting: explanation and elaboration. Qual Saf Health Care (2008) 4.59
Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol (2011) 3.69
Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut (2007) 3.58
Evidence of bias and variation in diagnostic accuracy studies. CMAJ (2006) 3.34
Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. PLoS Med (2008) 3.22
Posttraumatic stress disorder in survivors of acute lung injury: evaluating the Impact of Event Scale-Revised. Chest (2013) 3.00
International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst (2003) 2.75
A systematic review of the content of critical appraisal tools. BMC Med Res Methodol (2004) 2.39
Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst (2010) 2.29
Types of study in medical research: part 3 of a series on evaluation of scientific publications. Dtsch Arztebl Int (2009) 1.80
Clinical evaluation of a loop-mediated amplification kit for diagnosis of imported malaria. J Infect Dis (2013) 1.73
A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet (2010) 1.70
Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. Cancer Res (2012) 1.69
The Research Diagnostic Criteria for Temporomandibular Disorders. I: overview and methodology for assessment of validity. J Orofac Pain (2010) 1.67
Rapid, noninvasive detection of diabetes-induced retinal metabolic stress. Arch Ophthalmol (2008) 1.57
Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One (2014) 1.55
Clinical diagnosis of lacunar stroke in the first 6 hours after symptom onset: analysis of data from the glycine antagonist in neuroprotection (GAIN) Americas trial. Stroke (2007) 1.44
The status of spectral EEG abnormality as a diagnostic test for schizophrenia. Schizophr Res (2007) 1.44
Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Med (2012) 1.41
Relation of completeness of reporting of health research to journals' endorsement of reporting guidelines: systematic review. BMJ (2014) 1.41
The value of (18)F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma. Eur J Nucl Med Mol Imaging (2016) 1.39
Poor man's fluorescence? Acta Neurochir (Wien) (2015) 1.38
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
Selection in reported epidemiological risks: an empirical assessment. PLoS Med (2007) 1.30
Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev (2012) 1.30
Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomark Insights (2010) 1.30
The Acute Asthma Severity Assessment Protocol (AASAP) study: objectives and methods of a study to develop an acute asthma clinical prediction rule. Emerg Med J (2011) 1.28
Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant (2014) 1.26
Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart (2005) 1.24
New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y. PLoS Med (2006) 1.23
Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis. Clin Microbiol Rev (2016) 1.23
Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. J Cancer Res Clin Oncol (2010) 1.20
The Research Diagnostic Criteria For Temporomandibular Disorders. II: reliability of Axis I diagnoses and selected clinical measures. J Orofac Pain (2010) 1.18
Clinical characteristics of symptomatic vertebral artery dissection: a systematic review. Neurologist (2012) 1.15
The Research Diagnostic Criteria for Temporomandibular Disorders. III: validity of Axis I diagnoses. J Orofac Pain (2010) 1.15
The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination. J Gen Intern Med (2008) 1.13
Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative. Neurology (2014) 1.10
Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One (2012) 1.09
Creation and Critique of Studies of Diagnostic Accuracy: Use of the STARD and QUADAS Methodological Quality Assessment Tools. J Man Manip Ther (2007) 1.08
A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts. PLoS Med (2015) 1.06
Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout. Arthritis Care Res (Hoboken) (2015) 1.06
Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS One (2014) 1.06
Reproducibility of the STARD checklist: an instrument to assess the quality of reporting of diagnostic accuracy studies. BMC Med Res Methodol (2006) 1.06
Reliability and validity of Axis I of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) with proposed revisions. J Oral Rehabil (2010) 1.05
Checklists to improve the quality of the orthopaedic literature. Indian J Orthop (2008) 1.05
Hepatotoxicity related to antirheumatic drugs. Nat Rev Rheumatol (2011) 1.04
Performance of a malaria microscopy image analysis slide reading device. Malar J (2012) 1.04
Diagnostic accuracy of the rapid urine lipoarabinomannan test for pulmonary tuberculosis among HIV-infected adults in Ghana-findings from the DETECT HIV-TB study. BMC Infect Dis (2015) 1.04
Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis. Mol Clin Oncol (2014) 1.02
STRengthening analytical thinking for observational studies: the STRATOS initiative. Stat Med (2014) 1.01
A retrospective analysis of glycol and toxic alcohol ingestion: utility of anion and osmolal gaps. BMC Clin Pathol (2012) 1.01
How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study. J Gynecol Oncol (2012) 0.98
The Australian experiment: the use of evidence based medicine for the reimbursement of surgical and diagnostic procedures (1998-2004). Aust New Zealand Health Policy (2006) 0.98
Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis. Exp Ther Med (2012) 0.95
Standardization of diagnostic biomarker concentrations in urine: the hematuria caveat. PLoS One (2012) 0.95
Clinical outcomes using a faecal immunochemical test for haemoglobin as a first-line test in a national programme constrained by colonoscopy capacity. United European Gastroenterol J (2013) 0.95
Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery. PLoS One (2013) 0.94
The REFER (REFer for EchocaRdiogram) protocol: a prospective validation of a clinical decision rule, NT-proBNP, or their combination, in the diagnosis of heart failure in primary care. Rationale and design. BMC Cardiovasc Disord (2012) 0.93
DEALING WITH DISASTER DATABASES - WHAT CAN WE LEARN FROM HEALTH AND SYSTEMATIC REVIEWS?: Application in practice. PLoS Curr (2011) 0.92
EQUATOR: reporting guidelines for health research. Open Med (2008) 0.91
Whither osteoarthritis biomarkers? Osteoarthritis Cartilage (2009) 0.91
Diagnostic accuracy of circulating tumor cells detection in gastric cancer: systematic review and meta-analysis. BMC Cancer (2013) 0.90
Charting a roadmap for heart failure biomarker studies. JACC Heart Fail (2014) 0.90
Microalbuminuria: A novel biomarker of sepsis. Indian J Crit Care Med (2010) 0.90
Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases. Proteomics Clin Appl (2008) 0.89
Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis. PLoS One (2015) 0.89
Explanation and elaboration of the SQUIRE (Standards for Quality Improvement Reporting Excellence) Guidelines, V.2.0: examples of SQUIRE elements in the healthcare improvement literature. BMJ Qual Saf (2016) 0.88
Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study. PLoS One (2013) 0.88
Imaging characteristics of symptomatic vertebral artery dissection: a systematic review. Neurologist (2012) 0.88
Improving biomarker identification with better designs and reporting. Clin Chem (2011) 0.88
Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study. Biomed Res Int (2013) 0.87
Identifying continuous quality improvement publications: what makes an improvement intervention 'CQI'? BMJ Qual Saf (2011) 0.87
The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances. Int J Environ Res Public Health (2011) 0.87
Optimisation of prenatal group B streptococcal screening. Eur J Clin Microbiol Infect Dis (2003) 0.87
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open (2016) 0.87
A survey of the awareness, knowledge, policies and views of veterinary journal Editors-in-Chief on reporting guidelines for publication of research. BMC Vet Res (2014) 0.87
Neutrophil CD64: diagnostic accuracy and prognostic value in patients presenting to the emergency department. Eur J Clin Microbiol Infect Dis (2011) 0.86
Developing appropriate methodology for the study of surgical techniques. J R Soc Med (2009) 0.86
TREC Based Newborn Screening for Severe Combined Immunodeficiency Disease: A Systematic Review. J Clin Immunol (2015) 0.84
What affects authors' and editors' use of reporting guidelines? Findings from an online survey and qualitative interviews. PLoS One (2015) 0.84
Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer. Br J Cancer (2010) 0.84
Clinical and videofluoroscopic diagnosis of dysphagia in chronic encephalopathy of childhood. Radiol Bras (2015) 0.83
Emerging biomarkers for the diagnosis of severe neonatal infections applicable to low resource settings. J Glob Health (2011) 0.83
The Evidence Based Medicine approach to diagnostic testing: practicalities and limitations. Clin Biochem Rev (2005) 0.83
MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naïve men. Biomed Res Int (2015) 0.83
Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis. BMC Infect Dis (2011) 0.83
The diagnostic accuracy and validity of the teen screen questionnaire-mental health for clinical and epidemiological studies in primary-care settings. Indian J Psychol Med (2014) 0.83
Unacceptable performance and the lack of reproducibility results in the report of colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureus. J Clin Microbiol (2006) 0.83
Evaluating the impact and use of Transparent Reporting of Evaluations with Non-randomised Designs (TREND) reporting guidelines. BMJ Open (2012) 0.82
Measures of Diagnostic Accuracy: Basic Definitions. EJIFCC (2009) 0.82
Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection. Mediators Inflamm (2014) 0.81
The STARD initiative and the reporting of studies of diagnostic accuracy. Clin Chem (2003) 7.81
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 22.34
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med (2009) 21.74
Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol (2006) 20.17
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol (2003) 16.17
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2010) 16.11
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med (2011) 15.02
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol (2007) 13.46
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med (2009) 12.16
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol (2009) 11.80
Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med (2004) 11.47
Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust (2006) 11.40
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ (2003) 10.80
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med (2003) 10.28
Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med (2010) 9.30
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med (2003) 8.58
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem (2003) 7.92
Comparison of registered and published primary outcomes in randomized controlled trials. JAMA (2009) 7.89
Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med (2004) 7.87
The STARD initiative and the reporting of studies of diagnostic accuracy. Clin Chem (2003) 7.81
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol (2003) 7.54
Splinting vs surgery in the treatment of carpal tunnel syndrome: a randomized controlled trial. JAMA (2002) 7.31
Registering clinical trials. JAMA (2003) 7.21
Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med (2009) 6.88
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Med (2010) 6.88
Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med (2004) 6.87
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol (2010) 6.61
Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med (2006) 6.34
Hypothermia therapy after traumatic brain injury in children. N Engl J Med (2008) 6.10
The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res (2010) 6.09
Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol (2006) 6.03
Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem (2002) 6.03
The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol (2013) 5.93
How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med (2007) 5.86
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85
Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet (2012) 5.65
Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology (2008) 5.59
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA (2013) 4.98
Research misconduct, retraction, and cleansing the medical literature: lessons from the Poehlman case. Ann Intern Med (2006) 4.76
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
Corticosteroids as standalone or add-on treatment for sore throat. Cochrane Database Syst Rev (2012) 4.50
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med (2015) 4.49
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med (2009) 4.43
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev (2012) 4.36
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med (2015) 4.32
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials (2010) 4.28
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health (2013) 4.22
CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20
Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol (2002) 4.19
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials (2008) 4.17
An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol (2009) 3.98
Magnetic resonance imaging of the breast prior to biopsy. JAMA (2004) 3.97
CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 3.96
Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol (2006) 3.78